Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 Mar 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1286.75 [ +1.06% ]TCS 2427.20 [ -1.35% ]

Sensex29421.40
89.24 0.30%

Nifty9108.00
21.70 0.24%

Midcap13849.18
-4.22 -0.03%

Smallcap14077.61
49.67 0.35%



Alembic Pharmaceuticals Ltd :

 602.10  6.45 [1.08%]

ISIN: INE901L01018  | NSE: APLLTD |  Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln  |  BSE Code: 533573  |  Add To Watchlist

Price Information
• Open 600.00
• High 612.00
• Low 599.30
• Previous Close 595.65
• Shares Traded 70929500
• 52 Wk High Price 709.30
• 52 Wk High Date 23-03-2017
• 52 Wk Low Price 515.55
• 52 Wk Low Date 18-04-2016
• Face Value 2.00


Fundamentals
• Market Capital (Rs.cr) 11144.10
• EPS (Rs.)(TTM) 24.41
• P/E Ratio(TTM) 24.21
• Book Value (Rs.) 81.20
• Price to Book Value 7.28
• Equity (Rs.cr.) 37.70
• Traded Value (Rs.lac) 4973.24


Corporate Actions
Ex-Date Purpose (Rs.)
2012-07-31 70% Dividend (1.4)
2013-07-29 125% Dividend (2.5)
2014-07-17 150% Dividend (3)
2015-07-22 175% Dividend (3.5)
2016-07-20 200% Dividend (4)


Index Names
BSE HC
BSE-200
BSE Small Cap
BSE-500


Related Companies
Stock Name Price
BAJAJTEMPO 4607.05




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Dec, 2016 Dec, 2016 Mar, 2016
• Sales (Rs.cr) 797.63 2920.36 2991.74
• Net Profit (Rs.cr) 137.83 460.19 698.14
• Net Profit Var (%) -51.00 -32.00 144.00
• EPS (Rs) - 24.41 37.00
• P/E Ratio - 24.21 16.00
• Operating Profit Margin - 23.04 -
• CPS (Rs.) - - 40.90
• P/C Ratio - - 14.50
• Div% - - 200.00

Announcements
28-04-2016 Board of Alembic Pharmaceuticals recommends final dividend
29-06-2012 Alembic and Breckenridge announce paragraph IV ANDA litigation with Pfizer on desvenlafaxine (Prist
15-06-2012 Alembic Pharma settles patent litigation with Novartis for generic version of Exelon
03-03-2017 Alembic Pharmaceuticals announces launch of desvenlafaxine succinate ER tablets
18-11-2016 Alembic Pharmaceuticals gets ANDA approval for Telmisartan and Amlodipine Tablets
05-12-2016 Alembic Pharmaceuticals gets ANDA approval for Zolmitriptan Orally Disintegrating Tablets
22-10-2012 Alembic Pharmaceuticals received final approval for Modfinil tablets
16-12-2016 Alembic Pharmaceuticals receives ANDA approval for Itraconazole Capsules
02-05-2016 Alembic Pharmaceuticals receives final approval for Lacosamide Tablets
05-07-2016 Alembic Pharmaceuticals receives tentative approval for Febuxostat Tablets
03-05-2013 Alembic Pharmaceuticals Recommends Dividend
12-04-2012 Alembic Pharmaceuticals to consider dividend
05-06-2014 Alembic Pharmaceuticals to hold AGM
26-09-2014 Alembic Pharmaceuticals to hold board meeting
21-04-2016 Alembic Pharmaceuticals to set up JV with Orbicular
27-04-2015 Board of Alembic Pharmaceuticals appoints directors
10-01-2017 Board of Alembic Pharmaceuticals to consider Q3 results
28-07-2014 Outcome of board meeting of Alembic Pharmaceuticals

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
23-03-2017 1012836 1045655 96.86 602645764 622966.00
22-03-2017 830612 833212 99.69 495697815 497324.00
21-03-2017 2560 4636 55.22 1524608 2763.32
20-03-2017 2986 6199 48.17 1791003 3731.06
17-03-2017 2173 5486 39.61 1315535 3301.33


Bulk Deals
Deal Date Client Name Type Qty Price
23-03-2017 SHRENO LI B 1000000 595.00
23-03-2017 VIRAMYA P S 1000000 595.00


Block Deals
Deal Date Client Name Type Qty Price
23-03-2017 SHRENO LI B 1000000 595.00
23-03-2017 VIRAMYA P S 1000000 595.00
22-03-2017 SHRENO LI B 800000 597.00
22-03-2017 VIRAMYA P S 800000 597.00
19-05-2015 CRESTA FUND LIMITED B 620000 512.00


Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  sun tv network  •  lakshmi vilas bank  •  tata motors dvr  •  ester industries  •  coalin
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech